Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors
暂无分享,去创建一个
J. Ajani | C. Eng | M. Javle | D. Fogelman | B. Anderson | Kenzo Iizuka | Chun Zhang | Jackie Smith